Monural Pediatric (Fosfomycin Trometamol)

Fosfomycin trometamol, the active ingredient in Monural Pediatric, is a phosphonic acid antibiotic presented as an oral pediatric formulation for use in children. It is used to treat uncomplicated urinary tract infections caused by susceptible bacteria. GNH USA supplies Monural Pediatric as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Monural Pediatric, a phosphonic acid antibiotic, is indicated for bacterial infections of the urinary tract in the pediatric population. - Urinary tract infections: helps eradicate susceptible uropathogens and relieve infection symptoms in children.

Fosfomycin trometamol may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools occurring during treatment. - Headache: occasional mild headache. - Taste disturbance: altered taste perception.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, or swelling. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Clostridioides difficile infection: severe colitis risk. - Hepatic dysfunction: elevated liver enzymes. - Anaphylaxis: rare life‑threatening hypersensitivity.

Before prescribing Monural Pediatric, clinicians should consider several safety measures. - Renal function assessment: adjust use in impaired kidneys. - Hepatic monitoring: watch for liver enzyme changes. - Hydration status: ensure adequate fluid intake to reduce crystalluria. - Known hypersensitivity: avoid in patients allergic to fosfomycin or related compounds. - Pediatric dosing caution: follow prescriber guidance for age‑specific dosing. - Store below 25°C: keep in the original pack, protect from moisture.

Fosfomycin trometamol can affect, or be affected by, other medicines.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: reduce fosfomycin absorption. - Warfarin: may enhance anticoagulant effect. - Oral contraceptives: possible reduction in contraceptive efficacy.

Moderate Interactions (Monitor Closely): - Diuretics: may increase risk of electrolyte imbalance. - NSAIDs: monitor renal function when combined. - Other antibiotics (e.g., penicillins): assess for additive gastrointestinal effects.